Cargando…

Die nosokomiale Pneumonie: State-of-the-Art

Nosocomial pneumonia is among the most frequent infections in the intensive care unit with high morbidity and mortality. The decisive factor for treatment failure is inadequate previous antibiotic treatment. Broad spectrum and sufficiently high dosed initial treatment is crucial. To prevent further...

Descripción completa

Detalles Bibliográficos
Autor principal: Welte, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Steinkopff-Verlag 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101873/
https://www.ncbi.nlm.nih.gov/pubmed/32287633
http://dx.doi.org/10.1007/s00390-006-0721-2
_version_ 1783511712206422016
author Welte, T.
author_facet Welte, T.
author_sort Welte, T.
collection PubMed
description Nosocomial pneumonia is among the most frequent infections in the intensive care unit with high morbidity and mortality. The decisive factor for treatment failure is inadequate previous antibiotic treatment. Broad spectrum and sufficiently high dosed initial treatment is crucial. To prevent further resistances, the antibiotic treatment must be evaluated early. Depending on the treatment success, treatment has to be changed or terminated. Deescalation is possible and sensible after three days. A treatment period of seven days should not routinely be exceeded. The treatment recommendations should be adapted to local resistances and the local statistics of frequent pathogens. A further factor for treatment decision-making is the risk analysis of the patient (previous treatment, stays in hospitals or nursing homes, concomitant diseases).
format Online
Article
Text
id pubmed-7101873
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Steinkopff-Verlag
record_format MEDLINE/PubMed
spelling pubmed-71018732020-03-31 Die nosokomiale Pneumonie: State-of-the-Art Welte, T. Intensivmed Notfallmed Beitrag Zum Themenschwerpunkt Nosocomial pneumonia is among the most frequent infections in the intensive care unit with high morbidity and mortality. The decisive factor for treatment failure is inadequate previous antibiotic treatment. Broad spectrum and sufficiently high dosed initial treatment is crucial. To prevent further resistances, the antibiotic treatment must be evaluated early. Depending on the treatment success, treatment has to be changed or terminated. Deescalation is possible and sensible after three days. A treatment period of seven days should not routinely be exceeded. The treatment recommendations should be adapted to local resistances and the local statistics of frequent pathogens. A further factor for treatment decision-making is the risk analysis of the patient (previous treatment, stays in hospitals or nursing homes, concomitant diseases). Steinkopff-Verlag 2006 /pmc/articles/PMC7101873/ /pubmed/32287633 http://dx.doi.org/10.1007/s00390-006-0721-2 Text en © Steinkopff-Verlag 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Beitrag Zum Themenschwerpunkt
Welte, T.
Die nosokomiale Pneumonie: State-of-the-Art
title Die nosokomiale Pneumonie: State-of-the-Art
title_full Die nosokomiale Pneumonie: State-of-the-Art
title_fullStr Die nosokomiale Pneumonie: State-of-the-Art
title_full_unstemmed Die nosokomiale Pneumonie: State-of-the-Art
title_short Die nosokomiale Pneumonie: State-of-the-Art
title_sort die nosokomiale pneumonie: state-of-the-art
topic Beitrag Zum Themenschwerpunkt
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101873/
https://www.ncbi.nlm.nih.gov/pubmed/32287633
http://dx.doi.org/10.1007/s00390-006-0721-2
work_keys_str_mv AT weltet dienosokomialepneumoniestateoftheart